Genomic Health (GHDX) Tops Q1 EPS by 5c
Tweet
Share
E-mailGet Alerts GHDX Hot Sheet
Price: $63.44 --0%
Financial Fact:
Income (loss) from operations: -16.92M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Income (loss) from operations: -16.92M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Genomic Health (NASDAQ: GHDX) reported Q1 EPS of ($0.02), $0.05 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $83.98 million versus the consensus estimate of $86.19 million.
For earnings history and earnings-related data on Genomic Health (GHDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Omega Flex (OFLX) Tops Q2 EPS by 27c
- Boxlight Corporation (BOXL) Tops Q2 EPS by 2050c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
